Belite Bio (BLTE) net assets (shareholders' equity)

Net assets · fiscal 2025
$770.49M

Belite Bio (BLTE) had net assets of $770.49M at the end of fiscal 2025 (December 31, 2025). That is 428.4% higher than the $145.82M of fiscal 2024. Figures as of 18 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$770.49M
Change on fiscal 2024
+428.4%
Highest on record
$770.49Mfiscal 2025
Lowest on record
-$15.09Mfiscal 2021
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Belite Bio net assets (shareholders' equity), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $770.49M in fiscal 2025 and the lowest -$15.09M in fiscal 2021.

History · 6 fiscal years

Net assets by fiscal year

Belite Bio net assets (shareholders' equity), year by year

Belite Bio (BLTE) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$770.49M 428.4% up
2024$145.82M 61.3% up
2023$90.43M 117.9% up
2022$41.50M—
2021-$15.09M—
2020-$7.04M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Belite Bio and comparable companies
CompanyNet assetsFiscal year
RadNet RDNT$1.09B2025
Belite Bio BLTE$770.49M2025
Ligand Pharmaceuticals LGND$1.02B2025
Scholar Rock Holding SRRK$245.49M2025
Teleflex TFX$3.12B2025
Mirum Pharmaceuticals MIRM$314.69M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BLTE

Belite Bio, figure by figure

Belite Bio (BLTE) overview: price, valuation and scorecardAll health care companies by market value

Belite Bio net assets (shareholders' equity): questions and answers

What are Belite Bio's net assets?

Belite Bio (BLTE) had net assets of $770.49M at the end of fiscal 2025 (December 31, 2025). That is 428.4% higher than the $145.82M of fiscal 2024.

What are the highest and lowest net assets figures on record for Belite Bio?

Across the 6 fiscal years on record (2020–2025), the highest was $770.49M in fiscal 2025 and the lowest -$15.09M in fiscal 2021.

How is Belite Bio's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Belite Bio it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Belite Bio (BLTE) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/BLTE/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.